泌尿外科指南

订阅

MedSci主页 / 所有栏目 / 泌尿外科指南

中国前列腺癌早期诊断专家共识

2015-08-27 中华医学会泌尿外科学分会 中华泌尿外科杂志.2015,36(08):561-564.

前列腺癌早期诊断

我国前列腺癌发病率逐渐升高，多数地区新确诊患者中晚期比例高于欧美国家，这将对我国前列腺癌患者的治疗效果及长期生存产生直接影响。为促进泌尿外科同道科学、规范地开展前列腺癌早期诊断工作，编写成员在《中国泌尿外科疾病诊断治疗指南》的基础上，结合我国前列腺癌早期诊断现状，参考国外指南中的相关内容及最新文献报道，首次形成此“中国前列腺癌早期诊断专家共识”。

中文标题：

中国前列腺癌早期诊断专家共识

发布机构：

中华医学会泌尿外科学分会

发布日期：

2015-08-27

简要介绍：

我国前列腺癌发病率逐渐升高，多数地区新确诊患者中晚期比例高于欧美国家，这将对我国前列腺癌患者的治疗效果及长期生存产生直接影响。为促进泌尿外科同道科学、规范地开展前列腺癌早期诊断工作，编写成员在《中国泌尿外科疾病诊断治疗指南》的基础上，结合我国前列腺癌早期诊断现状，参考国外指南中的相关内容及最新文献报道，首次形成此“中国前列腺癌早期诊断专家共识”。

下载附件：
点击下载

(因为版权问题，不支持下载)

评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1191265, encodeId=599911912650c, content=棒！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=091f6328571, createdName=1048467_6430, createdTime=Tue Feb 08 23:18:44 CST 2022, time=2022-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191261, encodeId=2e3611912616d, content=学习了！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=091f6328571, createdName=1048467_6430, createdTime=Tue Feb 08 23:07:39 CST 2022, time=2022-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=362703, encodeId=035e362e0394, content=厉害，找到喜欢的app了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=01f52568974, createdName=1257c336m18暂无昵称, createdTime=Fri Mar 15 20:14:40 CST 2019, time=2019-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=225583, encodeId=e48422558361, content=更进一步了解了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/24/c26e935092765e8bfbde89e5237eb939.jpg, createdBy=86882090647, createdName=Dr.孙, createdTime=Sun Jul 23 23:40:19 CST 2017, time=2017-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=94185, encodeId=274a94185be, content=学习学习！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Fri Jul 22 20:15:00 CST 2016, time=2016-07-22, status=1, ipAttribution=)]
    2022-02-08 1048467_6430

    棒！

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1191265, encodeId=599911912650c, content=棒！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=091f6328571, createdName=1048467_6430, createdTime=Tue Feb 08 23:18:44 CST 2022, time=2022-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191261, encodeId=2e3611912616d, content=学习了！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=091f6328571, createdName=1048467_6430, createdTime=Tue Feb 08 23:07:39 CST 2022, time=2022-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=362703, encodeId=035e362e0394, content=厉害，找到喜欢的app了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=01f52568974, createdName=1257c336m18暂无昵称, createdTime=Fri Mar 15 20:14:40 CST 2019, time=2019-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=225583, encodeId=e48422558361, content=更进一步了解了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/24/c26e935092765e8bfbde89e5237eb939.jpg, createdBy=86882090647, createdName=Dr.孙, createdTime=Sun Jul 23 23:40:19 CST 2017, time=2017-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=94185, encodeId=274a94185be, content=学习学习！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Fri Jul 22 20:15:00 CST 2016, time=2016-07-22, status=1, ipAttribution=)]
    2022-02-08 1048467_6430

    学习了！

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1191265, encodeId=599911912650c, content=棒！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=091f6328571, createdName=1048467_6430, createdTime=Tue Feb 08 23:18:44 CST 2022, time=2022-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191261, encodeId=2e3611912616d, content=学习了！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=091f6328571, createdName=1048467_6430, createdTime=Tue Feb 08 23:07:39 CST 2022, time=2022-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=362703, encodeId=035e362e0394, content=厉害，找到喜欢的app了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=01f52568974, createdName=1257c336m18暂无昵称, createdTime=Fri Mar 15 20:14:40 CST 2019, time=2019-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=225583, encodeId=e48422558361, content=更进一步了解了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/24/c26e935092765e8bfbde89e5237eb939.jpg, createdBy=86882090647, createdName=Dr.孙, createdTime=Sun Jul 23 23:40:19 CST 2017, time=2017-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=94185, encodeId=274a94185be, content=学习学习！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Fri Jul 22 20:15:00 CST 2016, time=2016-07-22, status=1, ipAttribution=)]
    2019-03-15 1257c336m18暂无昵称

    厉害，找到喜欢的app了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1191265, encodeId=599911912650c, content=棒！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=091f6328571, createdName=1048467_6430, createdTime=Tue Feb 08 23:18:44 CST 2022, time=2022-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191261, encodeId=2e3611912616d, content=学习了！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=091f6328571, createdName=1048467_6430, createdTime=Tue Feb 08 23:07:39 CST 2022, time=2022-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=362703, encodeId=035e362e0394, content=厉害，找到喜欢的app了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=01f52568974, createdName=1257c336m18暂无昵称, createdTime=Fri Mar 15 20:14:40 CST 2019, time=2019-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=225583, encodeId=e48422558361, content=更进一步了解了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/24/c26e935092765e8bfbde89e5237eb939.jpg, createdBy=86882090647, createdName=Dr.孙, createdTime=Sun Jul 23 23:40:19 CST 2017, time=2017-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=94185, encodeId=274a94185be, content=学习学习！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Fri Jul 22 20:15:00 CST 2016, time=2016-07-22, status=1, ipAttribution=)]
    2017-07-23 Dr.孙

    更进一步了解了

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1191265, encodeId=599911912650c, content=棒！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=091f6328571, createdName=1048467_6430, createdTime=Tue Feb 08 23:18:44 CST 2022, time=2022-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191261, encodeId=2e3611912616d, content=学习了！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=091f6328571, createdName=1048467_6430, createdTime=Tue Feb 08 23:07:39 CST 2022, time=2022-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=362703, encodeId=035e362e0394, content=厉害，找到喜欢的app了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=01f52568974, createdName=1257c336m18暂无昵称, createdTime=Fri Mar 15 20:14:40 CST 2019, time=2019-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=225583, encodeId=e48422558361, content=更进一步了解了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/24/c26e935092765e8bfbde89e5237eb939.jpg, createdBy=86882090647, createdName=Dr.孙, createdTime=Sun Jul 23 23:40:19 CST 2017, time=2017-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=94185, encodeId=274a94185be, content=学习学习！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Fri Jul 22 20:15:00 CST 2016, time=2016-07-22, status=1, ipAttribution=)]
    2016-07-22 1dd8c52fm63(暂无匿称)

    学习学习！

    0

相关指南

前列腺癌根治术后辅助内分泌治疗热点问题和专家共识

中华医学会泌尿外科学分会(CUA) · 2015-08-30

2014年CA新前列腺癌幸存者指南

美国癌症学会(ACS,American Cancer Society) · 2016-04-20

2015 ASCO临床实践指南：前列腺癌生存者护理指南

美国临床肿瘤学会(ASCO,American Society of Clinical Oncology) · 2015-02-09

2014 SIOG推荐建议：老年前列腺癌的管理（更新版）

国际老年肿瘤学会(SIOG,International Society of Geriatric Oncology) · 2014-08-15

2014 ISUP共识会议：前列腺癌进行免疫组化检查的最佳实践建议

国际泌尿病理学会(ISUP,International Society of Urological Pathology) · 2014-08-01

2014 前列腺癌MR检查和诊断共识

中华放射学杂志编辑委员会 · 2014-07-30